Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • SKYEPHARMA PLC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2007 FY2006 FY2005 FY2004 FY2003
    Assets
    Cash and Short Term Investments 63.49 M 24.46 M 59.62 M 31.48 M 43.25 M
    Net Receivables 11.31 M 9.98 M 8.76 M 11.13 M 10.52 M
    Total Inventories 1.79 M 978,475.00 6.19 M 2.88 M 2.36 M
    Progress Payments & Others -595,239.00 -1.37 M -859,105.00 0.00 0.00
    Prepaid Expenses — — — — —
    Other Current Assets 11.90 M 18.40 M 15.64 M 23.80 M 17.40 M
    Current Assets Total 88.49 M 53.82 M 90.21 M 69.29 M 73.53 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 343,642.00 27.45 M 0.00
    Other Investments 198,413.00 195,695.00 2.75 M 9.98 M 39.33 M
    Property, Plant & Equipment Net 51.79 M 49.12 M 63.75 M 78.50 M 76.10 M
    Property, Plant & Equipment Gross 134.92 M 117.61 M 135.39 M 148.56 M 131.35 M
    Accumulated Depreciation 83.14 M 68.49 M 71.65 M 70.06 M 55.25 M
    Other Assets 71.43 M 107.63 M 164.09 M 183.11 M 169.81 M
    Deferred Charges 0.00 0.00 0.00 0.00 0.00
    Tangible Other Assets 0.00 33.46 M 0.00 0.00 0.00
    Intangible Other Assets 71.43 M 74.17 M 164.09 M 183.11 M 169.81 M
    Total Assets 211.91 M 210.76 M 321.13 M 368.33 M 358.77 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 13.49 M 16.83 M 5.84 M 25.53 M 8.09 M
    Accrued Payroll — — — — —
    Income Taxes Payable 1.19 M 978,475.00 5,758.17 5,357.13 4,830.93
    Dividends Payable — — — — —
    Other Current Liabilities 38.49 M 48.34 M 37.63 M 50.29 M 51.56 M
    Current Liabilities Total 65.87 M 83.76 M 55.15 M 88.68 M 70.21 M
    Long Term Debt 243.25 M 175.15 M 231.27 M 196.35 M 121.77 M
    Provision for Risks & Charges 4.37 M 3.72 M 3.26 M 3.26 M 3.79 M
    Deferred Taxes 0.00 0.00 13.06 M 0.00 0.00
    Deferred Income 15.87 M 14.48 M 4.98 M 4.41 M 5.26 M
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 0.00 13.50 M 5.84 M 5.57 M 6.18 M
    Total Liabilities 329.37 M 290.61 M 313.57 M 298.27 M 207.21 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 2.38 M 2.35 M 2.06 M 2.30 M 20.20 M
    Common Equity -119.84 M -82.19 M 5.50 M 67.75 M 131.36 M
    Common Stock 161.71 M 147.55 M 129.55 M 119.39 M 110.48 M
    Capital Surplus 759.52 M 732.09 M 593.81 M 616.12 M 551.99 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 396,826.00 391,390.00 1.03 M 61.23 M 16.70 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00 — —
    Retained Earnings -1.03 B -968.69 M -716.84 M -727.26 M -545.31 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 2.49 M
    Unrealized Foreign Exchange Gain (Loss) -8.13 M 6.46 M -2.06 M -1.73 M 0.00
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 0.00 0.00 0.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 211.91 M 210.76 M 321.13 M 368.33 M 358.77 M
    Common Shares Outstanding 814,988.64 753,764.15 753,764.15 648,390.11 644,505.60